Wednesday, September 30, 2026
spot_img

Don't Miss

RegenLab USA files for $35M IPO to accelerate growth of regenerative medicine portfolio

RegenLab USA has filed for a $35 million initial public offering on Nasdaq, proposing to list under the ticker RGNA. StoneX Financial is serving...

Clinical Trials

Galderma reports positive results for Restylane Volyme in temple hollowing

Galderma has reported positive topline results from a 162-patient Chinese study of Restylane Volyme, known as Restylane Contour in the U.S., for the correction...

Ourself study finds single regenerative serum outperforms three-product skincare regimen

Ourself has released results from an eight-week split-face study showing that its Advanced Regenerative Serum (ARS) outperformed a three-product skincare regimen across six of...

EVENTS

Funding

- Advertisement -

Featured

Latest Reviews

RegenLab USA files for $35M IPO to accelerate growth of regenerative medicine portfolio

RegenLab USA has filed for a $35 million initial public offering on Nasdaq, proposing to list under the ticker RGNA. StoneX Financial is serving...

Mergers & Acquisitions

Cytrellis partners with KoreAx to commercialize ellacor in South Korea

Cytrellis Biosystems has partnered with KoreAx Co. Ltd. to commercialize ellacor Micro-Coring technology in South Korea, marking the company’s second major international market expansion...

ACRE expands portfolio through new distribution partnerships

Aesthetic distributor ACRE has announced new distribution partnerships with IBSA Derma and ZO Skin Health, strengthening its presence in the UK medical aesthetics market. Get...

MRP signs exclusive US distribution agreement to bring Vydence Medical platforms to market

Medical Resource Partners (MRP) has entered an exclusive U.S. distribution agreement with Brazil-based Vydence Medical to bring three energy-based aesthetic platforms to the U.S....

Evolus partners with IBSA to bring Profhilo to the U.S.

Evolus has entered an exclusive licensing and distribution agreement with IBSA to develop and commercialize Profhilo® in the United States, expanding its injectable aesthetics...

LG Chem spins off aesthetics business in 3-way merger

A Korean private equity firm has combined LG Chem's aesthetics division with two smaller companies to create a standalone medical aesthetics group, the new...
- Advertisement -
Advertismentspot_imgspot_img
Advertismentspot_imgspot_img